Board Meeting7 Aug 2026, 11:43 am
Transgene Biotek Board Approves Unaudited Financial Results
AI Summary
Transgene Biotek Ltd's Board of Directors met on August 7, 2026, and approved the unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. The board also approved the limited review report for the same period. Additionally, the company received approval for the extension of its Annual General Meeting for the financial year 2025-26, subject to regulatory approval. M/s. Manisha Dubey & Associates were appointed as the Internal Auditors for the financial year 2026-27.
Key Highlights
- Board approved unaudited financial results for Q1 FY27.
- Limited review report for Q1 FY27 also approved.
- AGM date extension sought for FY26.
- Manisha Dubey & Associates appointed as Internal Auditors for FY27.
Price Impact
More from TRABI